Literature DB >> 6311893

Immunohistochemical demonstration of poly(adenosine diphosphate-ribose) synthetase in bovine tissues.

K Ikai, K Ueda.   

Abstract

The inter- and intracellular localization of poly(adenosine diphosphate-ribose)(poly(ADP-ribose] synthetase was investigated using an indirect immunofluorescence technique and a specific antibody against the enzyme purified from calf thymus. In various bovine tissues, including liver, heart, pancrease, thyroid, spleen, adrenal, and skeletal muscle, the specific immunofluorescence of poly(ADP-ribose) synthetase was localized exclusively in the nucleus. Immunostaining was inhibited by preabsorption of the antibody with purified calf thymus poly(ADP-ribose) synthetase. Nuclear immunofluorescence appeared to be more prominent in the marginal area than in the central region in most nuclei. This staining pattern is similar to that of naturally occurring poly(ADP-ribose). In bovine peripheral blood the immunofluorescence of poly(ADP-ribose) synthetase was detected in nuclei of lymphocytes, but not in granulocytes, in agreement with the finding that the enzymatic activity of poly(ADP-ribose) synthetase was barely detectable in nuclei isolated from granulocytes.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6311893     DOI: 10.1177/31.11.6311893

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  9 in total

1.  Inhibition of the activity of poly(ADP ribose) synthetase reduces ischemia-reperfusion injury in the heart and skeletal muscle.

Authors:  C Thiemermann; J Bowes; F P Myint; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

2.  5-Aminoisoquinolinone reduces colon injury by experimental colitis.

Authors:  Salvatore Cuzzocrea; Emanuela Mazzon; Rosanna Di Paola; Tiziana Genovese; Nimesh S A Patel; Carmelo Muià; Michael D Threadgill; Angelina De Sarro; Christoph Thiemermann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-11-18       Impact factor: 3.000

3.  Effects of inhibitors of the activity of poly (ADP-ribose) synthetase on the organ injury and dysfunction caused by haemorrhagic shock.

Authors:  M C McDonald; H M Filipe; C Thiemermann
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

Review 4.  Peroxynitrite in myocardial ischemia-reperfusion injury.

Authors:  Manoj M Lalu; Wenjie Wang; Richard Schulz
Journal:  Heart Fail Rev       Date:  2002-10       Impact factor: 4.214

5.  Cytoplasmic poly(ADP-ribose) polymerase and poly(ADP-ribose) glycohydrolase in AEV-transformed chicken erythroblasts.

Authors:  H Thomassin; C Martins de Sa; K Scherrer; C Maniez; P Mandel
Journal:  Mol Biol Rep       Date:  1988       Impact factor: 2.316

6.  Effects of 5-aminoisoquinolinone, a water-soluble, potent inhibitor of the activity of poly (ADP-ribose) polymerase on the organ injury and dysfunction caused by haemorrhagic shock.

Authors:  M C McDonald; H Mota-Filipe; J A Wright; M Abdelrahman; M D Threadgill; A S Thompson; C Thiemermann
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

Review 7.  Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review.

Authors:  Prabal K Chatterjee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-09-22       Impact factor: 3.000

8.  The guanine-quadruplex structure in the human c-myc gene's promoter is converted into B-DNA form by the human poly(ADP-ribose)polymerase-1.

Authors:  Anna Fekete; Erzsebet Kenesi; Eva Hunyadi-Gulyas; Hajnalka Durgo; Barbara Berko; Zsuzsanna A Dunai; Pal I Bauer
Journal:  PLoS One       Date:  2012-08-06       Impact factor: 3.240

9.  Poly(ADP-ribose) polymerase inhibition suppresses inflammation and promotes recovery from adrenal injury in a rat model of acute necrotizing pancreatitis.

Authors:  Jia Yu; Teng Zuo; Wenhong Deng; Qiao Shi; Peng Ma; Chen Chen; Liang Zhao; Kailiang Zhao; Weixing Wang
Journal:  BMC Gastroenterol       Date:  2016-07-27       Impact factor: 3.067

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.